Andrei Salomatov
Publications by Year
Research Areas
Computational Drug Discovery Methods, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Melanoma and MAPK Pathways, Autism Spectrum Disorder Research
Most-Cited Works
- → Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects(2022)14 cited
- → Preclinical efficacy of BDTX-4933, a brain penetrant MasterKey inhibitor targeting oncogenic BRAF Class I/II/III mutations(2022)2 cited
- → EGFR Oncogenes Expressed In Glioblastoma Are Activated As Covalent Dimers And Paradoxically Stimulated By Erlotinib(2019)2 cited
- → Data from Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects(2023)1 cited
- → Abstract P229: Pre-clinical evaluation of next-generation inhibitor targeting a wide spectrum of oncogenic BRAF dimers(2021)
- → Supplemental Materials from Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects(2024)
- → Supplementary Data from Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects(2023)